Home Featured Page 313

Featured

Latest

The War on Drugs Is a War On Mothers and Their Children

Burning Heroes Pitch Competition

Psilocybin for Cocaine Use Disorder: Peter Hendricks on a Trial Ten Years in the Making

Pα+ Psychedelic Bulletin #224: Reactions to Trump’s Psychedelics Executive Order, and What Comes Next; Pre-EO, DEA Poured Cold Water on Right to Try

NeonMind Submits Applications to Health Canada for Product Formulas to Support...

Nova Mentis Psilocybin Approved for Shipment to Italy

COMPASS Pathways expands its Discovery Center through new collaborations with world-leading...

Field Trip Health Ltd. Announces Official Opening of Psychedelic Research and...

Patent Combining Psychedelics with Cannabinoids Allowed by USPTO

Mind Cure Announces Closing of $23 Million Bought Deal Offering Including...

Bright Minds Biosciences Strengthens Scientific Advisory Team to Prepare for Future...

‘Pharmacopeia’ Season Finale Features Cutting Edge Psychedelic Research

The Role of Oxytocin in MDMA’s Prosocial Effects

The Ancestral Healing Power of Ayahuasca

EDITOR PICKS

The War on Drugs Is a War On Mothers and Their...

Burning Heroes Pitch Competition

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

The War on Drugs Is a War On Mothers and Their Children

Burning Heroes Pitch Competition

No Promises and No Goals

Psilocybin for Cocaine Use Disorder: Peter Hendricks on a Trial Ten Years in the Making

Pα+ Psychedelic Bulletin #224: Reactions to Trump’s Psychedelics Executive Order, and What Comes Next; Pre-EO, DEA Poured Cold Water on Right to Try

NeonMind Submits Applications to Health Canada for Product Formulas to Support...

Nova Mentis Psilocybin Approved for Shipment to Italy

COMPASS Pathways expands its Discovery Center through new collaborations with world-leading...

Field Trip Health Ltd. Announces Official Opening of Psychedelic Research and...

Patent Combining Psychedelics with Cannabinoids Allowed by USPTO

Mind Cure Announces Closing of $23 Million Bought Deal Offering Including...

Bright Minds Biosciences Strengthens Scientific Advisory Team to Prepare for Future...

‘Pharmacopeia’ Season Finale Features Cutting Edge Psychedelic Research

The Role of Oxytocin in MDMA’s Prosocial Effects

The Ancestral Healing Power of Ayahuasca

EDITOR PICKS

The War on Drugs Is a War On Mothers and Their...

Burning Heroes Pitch Competition

No Promises and No Goals

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY